DJIA 17,390.52 195.10 1.13%
NASDAQ 4,630.74 64.60 1.41%
S&P 500 2,018.05 23.40 1.17%
market minute promo

Gilead Sciences (NASDAQ: GILD)

112.00 -2.22 (-1.94%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $112.00 -1.94%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $115.90
Previous Close $114.22
Daily Range $110.76 - $116.83
52-Week Range $63.50 - $116.83
Market Cap $169.3B
P/E Ratio 19.04
Dividend (Yield) $0.00 (0.0%)
Volume 22,056,479
Average Daily Volume 14,752,082
Current FY EPS $8.14

Sector

Healthcare

Industry

Drugs

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary Rss Feed

5 Things McKesson Corporation's Management Wants You to Know

The Q2 numbers looked great, but here's what McKesson really wants investors to know.

Gilead Sciences has Multiple Growth Drivers

Gilead: Still 40% Upside Ahead

Did Gilead Sciences Really Disappoint With Its Earnings Announcement?

Jim Cramer's Top Stock Picks: CELG REGN GILD BIIB TTWO CRL FLEX

Jim Cramer's 'Mad Money' Recap: Here's Why the Bears Were Dead Wrong

Netflix and Gilead Will See More Gains, Says Thornburg Value Manager

United Therapeutics Sells Off On Good News - Why I Bought That Dip

Is Gilead Sciences a Worthy Investment?

5 Things Bristol-Myers Squibb Co.'s Management Wants You to Know

Bristol-Myers Squibb reported third-quarter earnings last week. Here are five things management wants investors to know.

See More GILD News...

GILD's Top Competitors

GILD $112.00 (-1.94%)
Current stock: GILD
AMGN $162.18 (0.37%)
Current stock: AMGN
CELG $107.09 (0.14%)
Current stock: CELG
$0.00 (0.00%)
Current stock: